Diagnostic tests that can determine the presence of different biological materials have become increasingly important to our health, food security and the environment. They support activities from the detection of food adulteration or specific pathogens within our foodstuffs and the environment to genetic and disease diagnostics for modern medicine. Identifying these by the targeted detection of specific DNA sequences within the unique genetic makeup of a species broadly describes molecular diagnostics.
In addition to DNA-based molecular diagnostics, alternative technologies can identify biological material based on specific, unique antigens, for example, proteins, carbohydrates and other biomolecules. These kinds of tests are often based on an immunoassay: the interaction of a specific antibody with its target. Increasingly, such tests can be found outside the laboratory and within the home; examples include the lateral flow test strips found in home pregnancy tests and, more recently, home-based coronavirus test kits.
RSK company ADAS and its biotechnology business are experts in these fields. We deliver innovative solutions to diagnostic issues for a range of clients through the development of bespoke diagnostic tests for diseases, pathogens, other biological markers and contaminants, and are also able to develop methodologies for routine testing or screening purposes.
Practical experience underpinned by robust science
ADAS has built a team comprising highly skilled scientists often working in collaboration with UK academics. Our combination of insight and practical experience, underpinned by robust, informed, science-based information, enables us to meet the needs of our domestic and international clients.